Manchester researchers win biomarker prize; RA multi-biomarker diagnostic could be better than disease markers;

> Researchers in Manchester win 2011 Cancer Research UK Prize for Translational Cancer Research for work on biomarker portfolio used in more than 70 clinical trials. Release

> Crescendo Bioscience's multi-biomarker blood test for rheumatoid arthritis could be more accurate than disease activity markers at identifying patients at risk for progression of joint damage. Release | Abstracts 323, 361, 1613 and 2244

> Banyan Biomarkers develops biomarker-based device to diagnose traumatic brain injury. Article

> Methylation detection could use cell-free circulating DNA to identify disease activity changes. Abstract

> C-Src-dependent beta-catenin Y333 phosphorylation levels could be used to select patients for Src inhibitors such as dasatinib for leukemia. Abstract

> ICGEB and Next Dimension Technologies developing electronic 'nose' that uses biomarkers to 'sniff out' TB. Story

> Succinate dehydrogenase subunit B (SDHB) has potential as a biomarker for malignant pheochromocytomas and paragangliomas to assess and manage disease. Abstract

> Mitomics and Bostwick Laboratories sign agreement--Bostwick to market ProstaClear Mitomic Test (PCMT). Release

> Celgene ($CELG) creates multiyear cancer deal with biomarker company Quanticel. Release

And Finally... 16-year old high school student wins Drexel University College of Medicine's Discovery Day 2011 with liver biomarker research--all studied in his own time. Article